Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

DNHD2 Inhibitors

DNHD2 inhibitors constitute a distinct class of small molecules that target and inhibit the enzymatic activity of histone deacetylase 2 (HDAC2), a specific member of the histone deacetylase enzyme family. HDACs are crucial regulators of gene expression by modulating the acetylation status of histone proteins, which are fundamental components of chromatin. Chromatin, composed of DNA wrapped around histones, can adopt varying degrees of compaction, thereby influencing the accessibility of DNA to transcriptional machinery. HDAC2, in particular, plays a pivotal role in epigenetic regulation by catalyzing the removal of acetyl groups from lysine residues on histone tails. This deacetylation event promotes a more condensed chromatin conformation, leading to transcriptional repression of associated genes. DNHD2 inhibitors are designed to interact with the active site of HDAC2, disrupting its catalytic function. This interaction prevents the removal of acetyl groups from histones, consequently maintaining an acetylated state of histone proteins.

The consequence of inhibiting HDAC2 activity with DNHD2 inhibitors is the promotion of an open chromatin structure due to the accumulation of acetyl groups on histone tails. This structural alteration enhances the accessibility of transcription factors and other regulatory proteins to DNA, potentially leading to increased gene transcription. The resulting gene expression changes can affect various cellular processes, including cell cycle control, differentiation pathways, and apoptotic responses. DNHD2 inhibitors, by selectively targeting HDAC2, enable researchers to unravel the intricate mechanisms underlying epigenetic regulation and chromatin remodeling. Understanding the role of HDAC2 in gene expression modulation provides insights into the broader landscape of epigenetic control and its impact on cellular functions. These inhibitors serve as valuable tools for investigating the complex interplay between epigenetic modifications, chromatin structure, and gene regulatory networks, ultimately contributing to the advancement of our knowledge in the field of molecular biology and cellular physiology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Inhibits HDAC activity, leading to increased acetylation of histones and non-histone proteins, resulting in altered gene expression, cell cycle arrest, and apoptosis in cancer cells.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Binds to and inhibits HDAC activity, promoting hyperacetylation of histones and other proteins, leading to cell cycle arrest, differentiation, and apoptosis in cancer cells.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Non-selective HDAC inhibitor that increases histone acetylation, altering gene expression, inducing cell cycle arrest, and promoting apoptosis in cancer cells.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$156.00
$572.00
(1)

Inhibits HDACs, causing histone hyperacetylation, modulation of gene expression, cell cycle arrest, and apoptosis in cancer cells.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Selective HDAC inhibitor, leading to increased histone acetylation, gene expression changes, cell cycle arrest, and apoptosis in cancer cells.

Scriptaid

287383-59-9sc-202807
sc-202807A
1 mg
5 mg
$64.00
$183.00
11
(2)

Enhances histone acetylation through HDAC inhibition, resulting in altered gene expression and anti-cancer effects.

CI 994

112522-64-2sc-205245
sc-205245A
10 mg
50 mg
$99.00
$536.00
1
(2)

Inhibits HDAC activity, leading to histone hyperacetylation, gene expression changes, and cell cycle arrest in cancer cells.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$214.00
$247.00
$1463.00
2
(1)

HDAC inhibitor causing histone acetylation, gene expression modulation, and cell cycle arrest, with potential anti-cancer effects.

Tubastatin A

1252003-15-8sc-507298
10 mg
$114.00
(0)

Selective HDAC6 inhibitor, affecting mainly cytoplasmic protein acetylation, with implications for neurodegenerative diseases and cancer.